Cargando…

Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer

Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandash, Fatima, Leger, David Y., Diab-Assaf, Mona, Sol, Vincent, Liagre, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659284/
https://www.ncbi.nlm.nih.gov/pubmed/34885849
http://dx.doi.org/10.3390/molecules26237268
_version_ 1784612928073236480
author Dandash, Fatima
Leger, David Y.
Diab-Assaf, Mona
Sol, Vincent
Liagre, Bertrand
author_facet Dandash, Fatima
Leger, David Y.
Diab-Assaf, Mona
Sol, Vincent
Liagre, Bertrand
author_sort Dandash, Fatima
collection PubMed
description Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and multifunctional uses, and their special affinity to cancer cells makes them the ligands par excellence for anticancer drugs. Porphyrin derivatives are used as the most important photosensitizers (PSs) for photodynamic therapy (PDT), which is a promising approach for anticancer treatment. Nevertheless, the lack of solubility and selectivity of the large majority of these macrocycles led to the development of different photosensitizer complexes. In addition, targeting agents or nanoparticles were used to increase the efficiency of these macrocycles for PDT applications. On the other hand, gold tetrapyrrolic macrocycles alone showed very interesting chemotherapeutic activity without PDT. In this review, we discuss the most important porphyrin derivatives, alone or associated with other drugs, which have been found effective against CRC, as we describe their modifications and developments through substitutions and delivery systems.
format Online
Article
Text
id pubmed-8659284
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86592842021-12-10 Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer Dandash, Fatima Leger, David Y. Diab-Assaf, Mona Sol, Vincent Liagre, Bertrand Molecules Review Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and multifunctional uses, and their special affinity to cancer cells makes them the ligands par excellence for anticancer drugs. Porphyrin derivatives are used as the most important photosensitizers (PSs) for photodynamic therapy (PDT), which is a promising approach for anticancer treatment. Nevertheless, the lack of solubility and selectivity of the large majority of these macrocycles led to the development of different photosensitizer complexes. In addition, targeting agents or nanoparticles were used to increase the efficiency of these macrocycles for PDT applications. On the other hand, gold tetrapyrrolic macrocycles alone showed very interesting chemotherapeutic activity without PDT. In this review, we discuss the most important porphyrin derivatives, alone or associated with other drugs, which have been found effective against CRC, as we describe their modifications and developments through substitutions and delivery systems. MDPI 2021-11-30 /pmc/articles/PMC8659284/ /pubmed/34885849 http://dx.doi.org/10.3390/molecules26237268 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dandash, Fatima
Leger, David Y.
Diab-Assaf, Mona
Sol, Vincent
Liagre, Bertrand
Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title_full Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title_fullStr Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title_full_unstemmed Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title_short Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
title_sort porphyrin/chlorin derivatives as promising molecules for therapy of colorectal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659284/
https://www.ncbi.nlm.nih.gov/pubmed/34885849
http://dx.doi.org/10.3390/molecules26237268
work_keys_str_mv AT dandashfatima porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer
AT legerdavidy porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer
AT diabassafmona porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer
AT solvincent porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer
AT liagrebertrand porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer